Patent 7790766 was granted and assigned to Theravance on September, 2010 by the United States Patent and Trademark Office.
The invention provides pharmaceutical compositions comprising a phenylacetic acid ester compound useful for inducing or maintaining general anesthesia or sedation in mammals, methods for preparing such compositions, and methods for inducing or maintaining anesthesia or sedation using such compositions.